D-0689-2021 Class III Terminated
FDA drug recall D-0689-2021 was initiated by Teligent Pharma, Inc. on Jun 22, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jul 3, 2024). Affected quantity: 7872 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 28, 2021
- Initiation Date
- Jun 22, 2021
- Termination Date
- Jul 3, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7872 tubes
Product description
Erythromycin Topical Solution USP, 2% 60 mL, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310, NDC 52565-027-59
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
Lot 14180
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0689-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026